Formulation development of venlafaxine hydrochloride extended release tablet and invitro characterizations

International Journal of PharmTech Research

Volumn 4, Issue 4, 2012, Pages 1777-1784

  Omprakash, Bagdiya ^a   Ajay, Sav ^a   Santosh, Gejage ^a   Amin, Purnima ^a  

^a INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

Extended release formulation; HPMC; Polyox; Venlafaxine hydrochloride

Indexed keywords

CARBOMER; METHYLCELLULOSE; VENLAFAXINE;

ARTICLE; BULK DENSITY; CHEMICAL INTERACTION; DRUG FORMULATION; DRUG MARKETING; DRUG RELEASE; DRUG STABILITY; FOURIER TRANSFORM INFRARED PHOTOACOUSTIC SPECTROSCOPY; IN VITRO STUDY; KINETICS; PARAMETERS; PHYSICAL CHEMISTRY; TABLET FRIABILITY; TABLET HARDNESS; THICKNESS; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 84875033263     PISSN: 09744304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Lui Y, Sun Y, Sun J. Int J Pharm, 2012, 426, 21-28.
2. Dierick A., Review of the efficacy and tolerability of Venlafaxine, Eur. Psychiatry 1997, 12, 307-13
3. Muth E. A., Moyer J. A., J. T. Haskins, Andree T. H. and Husbands G. E. M., Biochemical, neurophysiological and behavioural effects of Wy-45, 233, its enantiomers and otheridentified metabolites of the antidepressant venlafaxine, Drug Dev. Res., 1991, 23, 191-199.
4. Cusack B., Nelson A. and Richelson E., Binding of antidepressants to human brain receptors: focus on newer generation compounds, Psychopharmacol., 1994, 114, 559-565.
5. Muth E. A., Haskins J. T., Moyer J. A., Husbands G. E., Nielson S. T. and Sigg E. B., Antidepressant biochemical profile of the novel bicycliccompound Wy-45, 030, an ether cyclohexanol derivative, Biochem. Pharmacol. 1986, 35, 4493-4497.
6. Madgulkar A. R., Bhalekar M. R., Kolhe V. J. and Kenjale Y. D., Formulation and optimization of sustained release tablets of venlafaxine resonates using response surface methodology, Indian J. Pharm. Sci., 2009, 71, 387-394.
7. Wadher K. J., Kakde R. B. and Umekar M. J., Formulation and evaluation of a Sustaine release tablet of Metformin Hydrochloride using hydrophilic synthetic and hydrophobic natural polymers, Indian J. Pharm. Sci., 2011, 73, 208-215
8. Charulatha R., Kumaravel Rajan R., Design and evaluation of Carbamazepine controlled release drug delivery system, Int. J. PharmTech Res., 2012, 4, 25-34.
9. Troy S. M., Parker V. D., Fruncillo R. J. and Chiang S. T., The pharmacokinetics of Venlafaxine when given in a twice-daily regimen, J. Clin. Pharmacol. 1995, 35, 404-409
10. Wells J., Pharmaceutical preformulation: The physicochemical properties of drug sunstances. In: Aulton ME, Editor. Pharmaceutics the science of dosage form design London. Churchill Livingstone, 2002. P. 247
11. th edition, New Delhi. The controller of publication; 1996
12. Hadjiioannou T. P., Christian G. D., Koupparis M. A. and Macheras P. E. Quantitative Calculations in Pharmaceutical Practice and Research, VCH Publishers Inc., New York, 1993 pp. 345-348
13. Bourne D. W. A., Pharmacokinetics. In: Banker GS, Rhodes CT, Modern Pharmaceutics, 4th ed., Marcel Dekker Inc., New York, 2002, 67-92.
14. Hixson A. W., Crowell J. H., Dependence of reaction velocity upon surface and agitation (I) theoretical consideration. Ind. Eng. Chem., 1931, 23, 923-931.
15. Higuchi T., Mechanism of sustained action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J. Pharm. Sci., 1963, 52, 1145-1149.
16. Korsmeyer R. W., Von Meerwall E. and Peppas N. A., Solute and penetrant diffusion in swellable polymers. II. Verification of theoretical models. J. Polym. Sci. Polym. Phys. Ed., 1986b, 24, 409-434.